介绍了尿微量白蛋白的产生机理、临床意义以及分析进展。
The generation mechanism, clinical value and the analytical progress of microalbumin wre also reviewed.
目的了解肥胖症患儿尿微量白蛋白的改变及瘦素的致病作用。
Objective To understand change of microalbuminuria in adiposity and pathogenesis of leptin.
结论尿微量白蛋白测定是一种灵敏、简便、快速的测定方法。
Conclusion Microdose albumin detection is a sensitive, convenient and quick method which can be widely applied in the routine LABS.
体外循环前后血中可溶性细胞间粘附分子-1及尿微量白蛋白的变化。
Observation of the change of soluble intercellular adhesion molecules-1 and urea microalbumin during cardiopulmonary bypass.
结果高血压和糖尿病组病人中尿微量白蛋白的变化和肾损伤的程度呈正相关性。
Results Positive correlation is expressed between the level of kidney trauma and the variation of microdose albumin in the high blood pressure group patients and diabetes group patients.
目的探讨老年及高龄高血压患者尿微量白蛋白(mau)和大动脉僵硬度的关系。
Objective To explore the relationship between microalbuminuria (MAU) and stiffness of large artery in elderly and very elderly hypertensive patients.
实验结果显示尿微量白蛋白降低76.2%，表明罗布麻提取物起到显著的保护肾功能作用。
The results showed 76.2% reduction of urinary albumin, indicating that Apocynum extracts play a significant protection of renal function.
结论中药护肾胶囊可明显减少尿微量白蛋白排泄率，改善高血脂、高血黏滞状态，保护肾功能。
Conclusion Hushen capsule could reduce notably excretory rate of urine trace albumin, which could improve the blood viscosity, hyperlipidemia and renal function.
结果：依那普利治疗后尿微量白蛋白较治疗前明显减少（P<0.01）；空腹血糖与血压基本稳定。
Results:After using enalapril microdosis urinary albumin decreased obviously compared with that before treatment(P<0.01), while fasting blood glucose and blood pressure stabilized basically.
方法30例肥胖症患儿用免疫比浊法测定晨起尿微量白蛋白，同时测定血压、血糖、血脂、胰岛素、瘦素。
Methods Microalbuminuria was mensurated by immunoturbidmetric methods in 30 cases of adiposity in morning, meanwhile blood press, blood sugar, blood fat, blood insulin, blood leptin were mensurated.
对糖尿病组患者进行眼底、尿微量白蛋白、尿肌酐和颈动脉、股动脉、髂总动脉内中膜厚度（IMT）检查。
Eye fundus, urine microalbumin, urine creatinine and intima-media thickness(IMT) of carotid artery, femoral artery and common iliac artery were observed in diabetic group.
观察治疗前后症状积分变化，测定空腹血糖(FPS)、尿微量白蛋白排泄率(UAER)、血清NO水平及SOD活性。
Changes of symptoms, fasting plasma sugar (FPS), urine albumin excretion ratio (UAER), NO level and SOD activity in serum were observed.
结果糖肾汤能降低早期糖尿病肾病模型大鼠血糖、尿微量白蛋白、尿蛋白，提高肾组织SOD水平，减少肾组织MDA含量。
Results: Tangshen decoction could reduce the level of blood sugar and urine albumen, improve the level of SOD and reduce the content of MDA in kidney tissue of early diabetic nephropathy rats.
在进行了眼底检查的患者中，视网膜病变的患病率为57.9%，在进行了尿微量白蛋白筛查的患者中，微量白蛋白尿的患病率为49.0%。
Among the diabetic patients who had examined the eyeground or screened the microalbuminuria, the ratios of diabetic retinopathy and microalbuminuria were 57.9%, 49.0% respectively.
所以我们是在病人中观察新发生的微量白蛋白尿。
So we were looking at the developments of new microalbuminuria in these patients.
对患有微量白蛋白尿的2型糖尿病患者的深度多因素临床干预几乎阻止了糖尿病蛋白尿的进展，但却能改变GF R减低的结局。
Intensive multifactorial intervention in patients with type 2 diabetes with microalbuminuria nearly halved the progression of proteinuria but did not alter the rate of GFR decline.
此外，ROADMAP数据证明奥美沙坦可预防2型糖尿病患者发生微量白蛋白尿(mau)。
In addition, data from ROADMAP proved that olmesartan can reduce risk of microalbuminuria (MAU) in Type 2 diabetes (T2DM) patients.
微量白蛋白尿和DR患者GFR下降最快。
Patients with microalbuminuria and DR showed the fastest GFR decline.
目的观察在微量白蛋白尿发生前后应用氯沙坦对糖尿病肾病(DN)的治疗作用及其机制。
Objective To estimate the therapeutical effect and mechanism of losartan on diabetic nephropathy (DN) before and after microalbuminuria.
目的探讨微量白蛋白尿(MA)与非糖尿病急性心肌梗死(NDM AMI)患者预后的关系。
Objective To investigate prognostic significance of microalbuminuria (MA) in non-diabetic acute myocardial infarction (NDM-AMI) patients.
微量白蛋白尿组发生联合终点事件的机率较正常UACR组高43%。
Patients with microalbuminuria were 43 percent more likely to reach the combined end point than those with normal UACR.
结论普伐他汀可改善代谢综合征患者的血脂紊乱、高血压及微量白蛋白尿，可安全地应用于代谢综合征患者。
Conclusion Pravastatin can be safely used for treating metabolic syndrome because it can ameliorate the lipid disturbance, hypertension and microalbuminuria.
结论微量白蛋白尿的测定可用于监测、防治糖尿病性心脏病。
Conclusions The menstruations of micro albumin urine can be applied to the prevention of diabetic heart disease.
Bilou教授：根据我们现有的数据，就像今天汇报的那样，还不能说坎地沙坦（Candesatan）对微量白蛋白尿的一级预防是有用的。
Prof. R. W. Bilou: Well, at the moment from our data as presented today we can't say that Candesatan has a role for the primary prevention of microalbuminuria.
目的研究急性脑梗死患者微量白蛋白尿(mau)的发生率、与卒中危险因素及脑梗死复发的关系。
Objective to assess the prevalence of microalbuminuria (MAU) in patients with recent cerebral infarction and its associations to risk factors for stroke and recurrence.
巨量白蛋白尿的患者组，其肾病进展的危险因素与微量白蛋白尿组相似，其进展的患者肾小球滤过率较低（GFRs）且诊断有心血管疾病或心力衰竭。
The macroalbuminuria group had risk factors similar to the microalbuminuria group, and had lower glomerular filtration rates (GFRs) and a diagnosis of cardiovascular disease or heart failure.
目前正在进行观察性随访研究，以进一步了解预防微量白蛋白尿的长期益处。
An observational follow-up study is underway to further understand the long-term benefits of microalbuminuria prevention.
经过糖化血色素，胰岛素使用，微量白蛋白尿，心血管疾病和抑郁评分模型中的夹杂物，每一个有显着相关的预期寿命。
After inclusion of A1C, insulin use, microalbuminuria, cardiovascular disease, and depression scores in the model, each was significantly related to life expectancy.
至于微量白蛋白尿与胰岛素抵抗有直接的病理生理联系，还是仅与该综合征的某些代谢紊乱有关，目前尚不清楚。
It is still unclear whether microalbuminuria is directly associated with insulin resistance in pathophysiology or it is merely related...
我们研究了使用血管紧张素受体阻断剂（ARB）进行治疗是否能延缓或预防尿白蛋白正常的2型糖尿病患者出现微量蛋白尿。
We investigated whether treatment with an angiotensin-receptor blocker (ARB) would delay or prevent the occurrence of microalbuminuria in patients with type 2 diabetes and normoalbuminuria.
应用推荐